PEGASO: Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting (clinicaltrials.gov) - Feb 25, 2026 - P=N/A | N=75 | Not yet recruiting | Sponsor: Chiesi Italia | Initiation date: Jan 2026 ➔ Apr 2026
Real-world evidence • Trial initiation date • Fabry Disease • Genetic Disorders
|